Kennedy Capital Management’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-128,536
Closed -$346K 703
2024
Q3
$346K Sell
128,536
-191,610
-60% -$515K 0.01% 648
2024
Q2
$912K Sell
320,146
-1,377
-0.4% -$3.92K 0.02% 599
2024
Q1
$1.36M Sell
321,523
-4,762
-1% -$20.2K 0.03% 586
2023
Q4
$1.75M Sell
326,285
-5,062
-2% -$27.1K 0.04% 517
2023
Q3
$1.42M Hold
331,347
0.03% 525
2023
Q2
$1.82M Hold
331,347
0.04% 483
2023
Q1
$1.39M Hold
331,347
0.04% 447
2022
Q4
$918K Sell
331,347
-51
-0% -$141 0.03% 500
2022
Q3
$848K Sell
331,398
-513
-0.2% -$1.31K 0.03% 504
2022
Q2
$1.2M Buy
+331,911
New +$1.2M 0.03% 453
2021
Q2
Sell
-725,974
Closed -$3.96M 645
2021
Q1
$3.96M Sell
725,974
-252,479
-26% -$1.38M 0.08% 417
2020
Q4
$4.2M Sell
978,453
-98,899
-9% -$424K 0.09% 386
2020
Q3
$3.24M Sell
1,077,352
-359,075
-25% -$1.08M 0.09% 400
2020
Q2
$4.45M Buy
1,436,427
+266,479
+23% +$826K 0.13% 308
2020
Q1
$2.59M Sell
1,169,948
-391,456
-25% -$865K 0.1% 390
2019
Q4
$4.76M Buy
1,561,404
+442,852
+40% +$1.35M 0.12% 340
2019
Q3
$3.44M Buy
1,118,552
+918,552
+459% +$2.82M 0.09% 428
2019
Q2
$400K Buy
200,000
+177,398
+785% +$355K 0.01% 660
2019
Q1
$97K Buy
+22,602
New +$97K ﹤0.01% 681
2017
Q2
Sell
-490,909
Closed -$1.28M 721
2017
Q1
$1.28M Sell
490,909
-1,839
-0.4% -$4.78K 0.02% 646
2016
Q4
$1.5M Buy
492,748
+1,877
+0.4% +$5.73K 0.03% 635
2016
Q3
$1.34M Buy
+490,871
New +$1.34M 0.03% 634
2013
Q3
Sell
-168,649
Closed -$601K 760
2013
Q2
$601K Buy
+168,649
New +$601K 0.01% 681